Medtronic launches MiniMed Duo diabetes monitoring solution

Medtronic has announced the launch of MiniMed Duo, a groundbreaking two-part integrated insulin pump therapy and continuous glucose monitoring solution.

It is the world's first two-in-one breakthrough that combines a glucose sensor and insulin infusion set into one on-body device. It is designed for use in tandem with the MiniMed Veo system and offers a number of simplicity and comfort benefits.

The system provides people with diabetes with real-time information about their glucose levels and is the only integrated device with an automatic insulin shut-off mechanism if levels fall too low, providing protection against hypoglycaemia.

Greg Meehan, vice-president and general manager of the continuous glucose monitoring business at Medtronic Diabetes, said: "MiniMed Duo is the latest breakthrough designed in response to the needs of insulin pumpers who don't want to wear two separate devices on their bodies."

The CE Mark-approved product will be made available in a number of countries in the next few months as part of a progressive rollout across Europe.

It comes after the Medtronic also confirmed the launch of the Advisa and Ensura SR MRI SureScan single-chamber pacemaker devices in the EU earlier this month.